Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Association of FGFR4 genetic polymorphisms with prostate cancer risk and prognosis.

Prostate cancer and prostatic diseases - 1 Jan 2009

FitzGerald L M, Karlins E, Karyadi D M, Kwon E M, Koopmeiners J S, Stanford J L, Ostrander E A

Abstract excerpt

The fibroblast growth factor receptor 4 (FGFR4) is thought to be involved in many critical cellular processes and has been associated with prostate cancer risk. Four single nucleotide polymorphisms (SNPs) within or near FGFR4 were analyzed in a population-based study of 1458 prostate cancer patients and 1352 age-matched controls. We found no evidence to suggest that any of the FGFR4 SNP genotypes were associated...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Biomarkers, Tumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Case-Control Studies

Share to Prognosis

Share to Prostatectomy

Share to Prostatic Neoplasms

Share to Receptor, Fibroblast Growth Factor, Type 4

Share to Risk Factors

Source

Open in PubMed Open full text

Identifiers

PMID: 18762813
DOI: 10.1038/pcan.2008.46
PMCID: PMC2790323

Genes

FGFR4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Association of FGFR4 genetic polymorphisms with prostate cancer risk and prognosis.PMID 18762813Read ↗

An updated meta-analysis of the association between fibroblast growth factor receptor 4 polymorphisms and susceptibility to cancer.Semantic proximity Read ↗

FGFR4 Gly388Arg polymorphism contributes to prostate cancer development and progression: a meta-analysis of 2618 cases and 2305 controls.Semantic proximity Read ↗

Association between fibroblast growth factor receptor-4 gene polymorphism and risk of prostate cancer: a meta-analysis.Semantic proximity Read ↗

FGFR4 Gly388Arg polymorphism and prostate cancer risk in Scottish men.Semantic proximity Read ↗

Prognostic significance of fibroblast growth factor receptor 4 polymorphisms on biochemical recurrence after radical prostatectomy in a Chinese population.Semantic proximity Read ↗

The fibroblast growth factor receptor-4 Arg388 allele is associated with prostate cancer initiation and progression.Semantic proximity Read ↗

Altered fibroblast growth factor receptor 4 stability promotes prostate cancer progression.Semantic proximity Read ↗

Selective over-expression of fibroblast growth factor receptors 1 and 4 in clinical prostate cancer.Semantic proximity Read ↗

Individual and cumulative effect of prostate cancer risk-associated variants on clinicopathologic variables in 5,895 prostate cancer patients.Semantic proximity Read ↗

Effects of FGFR4 G388R, V10I polymorphisms on the likelihood of cancer.Semantic proximity Read ↗

Genetic association of the KLK4 locus with risk of prostate cancer.Semantic proximity Read ↗

FGFR-4 Arg³⁸⁸ enhances prostate cancer progression via extracellular signal-related kinase and serum response factor signaling.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.